Menu
Recombinant proteins are produced using recombinant DNA technology, primarily expressed in host cells such as E. coli or yeast. They are widely used in therapeutic protein drugs, vaccine development, drug delivery, immunoassays, and diagnostic reagents. Recombinant proteins also play key roles in antibody target screening, CAR-T cell therapy, ADCs, enzymes, viral proteins, and cytokine research.
Yaohai Bio-Pharma provides one-stop CMC research and GMP manufacturing services for a wide range of recombinant proteins, including peptides, cytokines, growth factors, enzymes, and virus-like particles (VLPs). With a well-established CRDMO platform and extensive project experience, the company is capable of meeting diverse commercial needs across different stages of recombinant protein drug development.
Yaohai Bio-Pharma delivers tailored solutions for global clients, meeting diverse project requirements with excellence and efficiency.
Proven track record of over 100 successful projects, spanning preclinical studies and Phase I/II/III clinical trials, including US–China dual submissions and Australian regulatory filings.
A robust GMP-aligned quality system with standardized SOPs, fully compliant with global regulatory guidelines across the entire product lifecycle.
Powered by industry-leading scientists and cross-functional experts, our team delivers CRDMO projects with speed, precision, and deep technical insight.
